01/24/2026
While traditional NAD⁺ precursors like NMN and NR rely on specific enzymatic pathways (NRK/NAMPT), Senolyte™ NMNH takes a faster, more potent route. Research shows it elevates NAD⁺ levels more rapidly and effectively, delivering superior bioavailability, quicker restoration, and enhanced support for metabolism, DNA repair, mitochondrial function, and longevity.
Key advantages of Senolyte™ NMNH:
+ Ultra-pure (>99% HPLC purity) with remarkable stability (low hygroscopicity, minimal degradation)
+ Superior potency: outperforms conventional precursors in cellular NAD⁺ enhancement
+ Clean-label & flexible: ideal for capsules, gummies, powders, or premium anti-aging formulas
+ Evidence-based: backed by peer-reviewed studies on NMNH's unique mechanism
In a market exploding toward $8B+ in anti-aging & senolytics by 2034, brands need ingredients that stand out. Senolyte™ NMNH gives you that edge: consistent performance, traceable quality, and real differentiation.
Ready to future-proof your formulations?
Visit www.eca-senolyte.com for specs, whitepapers, and samples
Email inquiry@ecahealthcareusa.com or DM us to discuss bulk, custom grades, or co-development
What’s your take on next-gen NAD⁺ precursors?
Is NMNH on your radar for 2026 launches? Drop a comment below, let's connect on building the future of healthy aging!